Antiphospholipid Syndrome (APS) Market Size, Share, Trends, Growth, Key Companies, Emerging Drugs and Epidemiology Forecast

Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the immune system misguidedly creates antibodies that make one’s blood substantially more likely to clot. It is also known as Hughes syndrome or lupus anticoagulant syndrome. Those with APS make abnormal proteins known as antiphospholipid autoantibodies (aPL) in the blood. This causes blood to flow improperlyContinue reading “Antiphospholipid Syndrome (APS) Market Size, Share, Trends, Growth, Key Companies, Emerging Drugs and Epidemiology Forecast”

Design a site like this with WordPress.com
Get started